TIAA CREF INVESTMENT MANAGEMENT LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q1 2019$3,852,000
-10.1%
169,910
+1.5%
0.00%0.0%
Q4 2018$4,283,000
-58.8%
167,371
-47.4%
0.00%0.0%
Q3 2018$10,386,000
+267.9%
317,932
+155.4%
0.00%
+50.0%
Q2 2018$2,823,000
-6.7%
124,471
-0.3%
0.00%0.0%
Q1 2018$3,027,000
-13.8%
124,812
-0.8%
0.00%0.0%
Q4 2017$3,510,000
-23.1%
125,849
-5.6%
0.00%
-33.3%
Q3 2017$4,563,000
-25.7%
133,266
-13.6%
0.00%
-25.0%
Q2 2017$6,142,000
+31.7%
154,158
+21.7%
0.00%
+33.3%
Q1 2017$4,665,000
+8.0%
126,686
-6.5%
0.00%0.0%
Q4 2016$4,320,000
-2.6%
135,501
+10.7%
0.00%0.0%
Q3 2016$4,436,000
+56.5%
122,401
-2.0%
0.00%
+50.0%
Q2 2016$2,834,000
+73.8%
124,919
+44.0%
0.00%
+100.0%
Q1 2016$1,631,000
+22.3%
86,779
+6.6%
0.00%0.0%
Q4 2015$1,334,000
+43.1%
81,404
-4.0%
0.00%0.0%
Q3 2015$932,000
-14.2%
84,816
+1.6%
0.00%0.0%
Q2 2015$1,086,000
-25.4%
83,447
-0.6%
0.00%0.0%
Q1 2015$1,456,000
+16.3%
83,9310.0%0.00%0.0%
Q4 2014$1,252,000
-49.6%
83,931
-22.1%
0.00%
-50.0%
Q3 2014$2,483,000
-34.8%
107,743
-9.7%
0.00%
-33.3%
Q2 2014$3,806,000119,3780.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders